Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study (Q83442994)
Jump to navigation
Jump to search
scientific article published on February 17, 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study |
scientific article published on February 17, 2011 |
Statements
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study (English)
Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study (English)
1 reference
Vicente E. Torres
Esther Meijer
Eiji Higashihara
Kyongtae T. Bae
Arlene B. Chapman
Ron T. Gansevoort
Jared J. Grantham
Ronald D. Perrone
Holly B. Krasa
John J. Ouyang
Frank S. Czerwiec
17 February 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference